Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BMC 2018-05-01
Sarja:Experimental Hematology & Oncology
Aiheet:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
Linkit:http://link.springer.com/article/10.1186/s40164-018-0104-y
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia